Viral outbreaks need a first line of antiviral strategies to tackle emerging viruses since the on-demand development of vaccines or antibody treatment is not always feasible. To address this problem, the Universidade Católica’s Biomedical Research Centre has been investigating the host-pathogen interactions in influenza A virus (IAV) infection.